Gray Wealth Management Inc. Abb Vie Inc. Transaction History

Gray Wealth Management Inc.

$251 Million
Q3 2024

A detailed history of Gray Wealth Management Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Gray Wealth Management Inc. holds 4,126 shares of ABBV stock, worth $699,893. This represents 0.32% of its overall portfolio holdings.

Number of Shares

4,126

Previous 3,980 3.67%

Holding current value

$699,893

Previous $682,000 19.35%

% of portfolio

0.32%

Previous 0.29%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	BUY	$163.84 - $199.33 $23,920 - $29,102	146 Added 3.67%	4,126 $814,000
Q2 2024 Aug 09, 2024	BUY	$154.79 - $180.76 $9,751 - $11,387	63 Added 1.61%	3,980 $682,000
Q1 2024 May 02, 2024	BUY	$159.82 - $182.1 $35,639 - $40,608	223 Added 6.04%	3,917 $713,000
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $125,628 - $141,487	-913 Reduced 19.82%	3,694 $572,000
Q3 2023 Oct 27, 2023	BUY	$133.59 - $154.65 $3,072 - $3,556	23 Added 0.5%	4,607 $686,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $22,924 - $28,527	173 Added 3.92%	4,584 $617,000
Q1 2023 Apr 11, 2023	BUY	$144.61 - $166.54 $26,174 - $30,143	181 Added 4.28%	4,411 $702,000
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $829 - $995	-6 Reduced 0.14%	4,230 $684,000
Q3 2022 Jan 03, 2023	BUY	$134.21 - $153.93 $5,368 - $6,157	40 Added 0.95%	4,236 $568,000
Q2 2022 Jan 03, 2023	SELL	$137.62 - $174.96 $825 - $1,049	-6 Reduced 0.14%	4,196 $643,000
Q1 2022 Jan 03, 2023	BUY	$131.98 - $163.75 $15,837 - $19,650	120 Added 2.94%	4,202 $681,000
Q4 2021 Jan 03, 2023	BUY	$107.43 - $135.93 $16,973 - $21,476	158 Added 4.03%	4,082 $553,000
Q3 2021 Jan 03, 2023	SELL	$106.4 - $120.78 $49,156 - $55,800	-462 Reduced 10.53%	3,924 $423,000
Q2 2021 Jan 03, 2023	SELL	$105.21 - $117.21 $13,887 - $15,471	-132 Reduced 2.92%	4,386 $494,000
Q1 2021 Jan 03, 2023	BUY	$102.3 - $112.62 $462,191 - $508,817	4,518 New	4,518 $489,000
Q4 2020 Jan 13, 2023	SELL	$80.49 - $108.67 $38,152 - $51,509	-474 Reduced 13.25%	3,104 $334,000
Q3 2020 Jan 13, 2023	BUY	$85.91 - $100.83 $96,906 - $113,736	1,128 Added 46.04%	3,578 $316,000
Q2 2020 Jan 13, 2023	SELL	$73.37 - $98.18 $131,038 - $175,349	-1,786 Reduced 42.16%	2,450 $238,000

Others Institutions Holding ABBV

# of Institutions

3,817

Shares Held

1.25B

Call Options Held

13M

Put Options Held

10M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gray Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Gray Wealth Management Inc. with notifications on news.

Account

Gray Wealth Management Inc. Abb Vie Inc. Transaction History